Hwang Se Hwan, Kim Sung Won, Kim Soo Whan, Kim Byung Guk, Cho Jin Hee, Kang Jun Myung
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, 327 Sosa-ro, Bucheon-si, Gyeonggi-do, 14647, Republic of Korea.
Eur Arch Otorhinolaryngol. 2019 Jan;276(1):3-10. doi: 10.1007/s00405-018-5138-6. Epub 2018 Sep 20.
The use of greater palatine canal (GPC) injections of a local anesthetic and a vasoconstrictor to decrease surgical bleeding during endoscopic sinus surgery (ESS) is controversial. We investigated the role of a preoperative GPC injection to minimize intraoperative bleeding during ESS in patients with chronic sinusitis through a meta-analysis of the relevant literature.
PubMed, SCOPUS, and the Cochrane database.
We screened the relevant literature published before May of 2018. Five articles that compared the pre-operative GPC injection (treatment group) with a placebo or no treatment (control group) were included for this analysis of the outcomes, which included an endoscopic grade of nasal bleeding and intraoperative hemodynamic stability during ESS.
The endoscopic grade in the treatment group was significantly reduced when compared with the control group. No significant adverse effects were reported in the enrolled studies. The subgroup analyses of these results compared the concentrations of adrenalin (1:80,000 or 1:100,000), and adrenalin 1:80,000 showed significant effects on intraoperative bleeding when compared to adrenalin 1:100,000.
This study demonstrated that GPC injections of local anesthesia with 1:80,000 adrenaline for ESS effectively reduced intraoperative bleeding. Additionally, this procedure showed no significant adverse effects, such as hemodynamic instability. However, the standardized dosing needs further investigation and more trials.
Ia.
在内镜鼻窦手术(ESS)中,使用腭大管(GPC)注射局部麻醉剂和血管收缩剂以减少手术出血存在争议。我们通过对相关文献的荟萃分析,研究术前GPC注射在慢性鼻窦炎患者ESS中减少术中出血的作用。
PubMed、SCOPUS和Cochrane数据库。
我们筛选了2018年5月之前发表的相关文献。纳入了5篇将术前GPC注射(治疗组)与安慰剂或不治疗(对照组)进行比较的文章,用于分析结局,包括ESS期间的鼻内镜下鼻出血分级和术中血流动力学稳定性。
与对照组相比,治疗组的内镜分级显著降低。纳入研究中未报告明显不良反应。这些结果的亚组分析比较了肾上腺素浓度(1:80,000或1:100,000),与1:100,000肾上腺素相比,1:80,000肾上腺素对术中出血有显著影响。
本研究表明,ESS时在GPC注射1:80,000肾上腺素进行局部麻醉可有效减少术中出血。此外,该操作未显示出明显的不良反应,如血流动力学不稳定。然而,标准化给药需要进一步研究和更多试验。
Ia级。